US FDA approves Bayer drug for specific type of lung cancer

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
CURE

FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...
MedPage Today on MSN

New FDA-Approved Option for HER2-Mutated Lung Cancer

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
MedPage Today on MSN

Triglyceride-Lowering Drug Gets FDA Nod for Rare Genetic Disorder

The small interfering RNA (siRNA) therapy, designed to reduce triglyceride levels by suppressing production of apolipoprotein ...
The American Journal of Managed Care

FDA Approves Sevabertinib for Nonsquamous NSCLC

The FDA has granted an accelerated approval for the use of sevabertinib in patients with nonsquamous non–small cell lung cancer (NSCLC) whose tumors have HER2 ( ERBB2) tyrosine kinase domain (TKD) ...

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...
Targeted Oncology

FDA Grants Daratumumab and Hyaluronidase-fihj Traditional Approval for Newly Diagnosed Light Chain Amyloidosis

The ANDROMEDA trial showed improved MOD-PFS and OS with daratumumab and hyaluronidase plus VCd compared to VCd alone in light ...

SMX Brings Identity to American Plastics as FDA-Compliant Molecular Marking Turns rPET Into a Certified Commodity

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / For decades, plastics have moved through the world without an identity. They were manufactured, used, discarded, shredded, melted, and remade, but ...

FDA-approved blood test provides simpler option for colon cancer screening

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally ...
The American Journal of Managed Care

Global Gaps in Drug Access After FDA Approval: Insights From New Study and Ethics Guidelines

Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...